5AM VENTURES LLC 3
3 · KALOBIOS PHARMACEUTICALS INC · Filed Aug 10, 2012
Insider Transaction Report
Form 3
5AM Partners LLC
10% Owner
Holdings
- 572,295
Common Stock
Series B-2 Preferred Stock
→ Common Stock (624,999 underlying)Series B-1 Preferred Stock
→ Common Stock (445,847 underlying)Series C Preferred Stock
→ Common Stock (284,513 underlying)Series D Preferred Stock
→ Common Stock (344,084 underlying)
Footnotes (7)
- [F1]The shares are held as follows: 500,758 shares by 5AM Ventures LLC ("Ventures") and 71,537 shares by 5AM Co-Investors LLC ("Co-Investors"). 5AM Partners LLC is the general partner of Ventures and Co-Investors. The managing directors of 5AM Partners LLC are Dr. John D. Diekman and Andrew J. Schwab.
- [F2]Each share of Preferred Stock is convertible at any time, at the election of the holder, into one fully paid and nonassessable share of Common Stock, subject to certain anti-dilution adjustments.
- [F3]No expiration.
- [F4]The shares are held as follows: 390,116 shares by Ventures and 55,731 shares by Co-Investors.
- [F5]The shares are held as follows: 546,874 shares by Ventures and 78,125 shares by Co-Investors.
- [F6]The shares are held as follows: 249,360 shares by Ventures and 35,153 shares by Co-Investors.
- [F7]The shares are held as follows: 301,570 shares by Ventures and 42,514 shares by Co-Investors.